Prevalence of Y chromosome deletions in a Brazilian population of nonobstructive azoospermic and severely oligozoospermic men by São Pedro, Simone Lima et al.
787
Braz J Med Biol Res 36(6) 2003
Yq deletions in Brazilian infertile menBrazilian Journal of Medical and Biological Research (2003) 36: 787-793
ISSN 0100-879X
Prevalence of Y chromosome
deletions in a Brazilian population
of nonobstructive azoospermic and
severely oligozoospermic men
1Seção de Endocrinologia Experimental, Departamento de Farmacologia, and
2Seção de Reprodução Humana, Departamento de Medicina e Ginecologia
and Divisão de Urologia, Universidade Federal de São Paulo,
Escola Paulista de Medicina, São Paulo, SP, Brasil
S.L. SãoPedro1,2,
R. Fraietta2, D. Spaine2,
C.S. Porto1, M. Srougi2,
A.P. Cedenho2 and
M.C.W. Avellar1
Abstract
We determined the prevalence of Y chromosome deletions in a
population of 60 Brazilian nonobstructive azoospermic and severely
oligozoospermic men. PCR-based screening of microdeletions was
performed on lymphocyte DNA for the presence of 14 sequence-
tagged sites (STS) located in the azoospermic factor (AZF) on the Yq
chromosome. All STS were amplified efficiently in samples from 12
fertile men tested, but failed to be amplified in samples from fertile
women, indicating the specificity of PCR conditions for Yq screening.
Overall, 4 of the 60 infertile patients tested (6.7%) exhibited deletion
of the Y chromosome, 2 of them being severely oligozoospermic
patients (P10 and P32) and 2 azoospermic men (patients P47 and P57).
Patients P47 and P57 presented larger deletions in the AZFa, AZFb
and AZFc subregions, with apparent loss of Yq material evidenced by
karyotype analysis. Patients P10 and P32 presented deletions confined
to the AZFc region, involving the DAZ locus. Male relatives of
patients P10 and P32 had no Y chromosome deletions and presented
a normal karyotype, suggesting a de novo status of the deletions found.
Our data add to the growing literature showing that microdeletions of
the Y chromosome can be the cause of male idiopathic infertility.
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Introduction
The existence of a gene, or a gene com-
plex, associated with normal spermatogen-
esis was first postulated on the basis of a
cytogenetic analysis that showed macroscopic
deletions of the distal part of the Y chromo-
some (Yq11) in men with azoospermia (1).
This gene or gene cluster was defined as
azoospermia factor (AZF). Subsequent PCR-
based screening studies used to amplify se-
quence-tagged sites (STS) spanning the Y
chromosome (2,3) facilitated the detection
of small interstitial deletions (i.e., microde-
letions) of Yq11 not only in azoospermic (4-
6), but also in severely oligozoospermic men
(7,8). Since these deletions were variable in
both extent and location, the AZF region was
divided into three nonoverlapping subregions
(AZFa, AZFb and AZFc) located from the
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proximal to the distal part of Yq (6). Recent
genetic studies have shown that several genes
or gene families located in AZF regions are
specifically expressed in the testis and could
therefore be considered as AZF candidate
genes for infertility, such as the RBM (RNA-
binding motif) and the DAZ (deleted in
azoospermia) gene families (for reviews, see
Refs. 9-11). Recently, a fourth AZF subre-
gion (AZFd) between AZFb and AZFc has
been proposed (12). Men with deletions lo-
cated exclusively in the AZFd subregion
present mild oligozoospermia or even nor-
mal sperm counts associated with normal
sperm morphology (12), but a candidate gene
has not yet been found in this region.
Over the past few years, screening tests
for detecting microdeletions on the long arm
of the Y chromosome have established the
distribution and characteristics of the dele-
tions among different groups of infertile male
patients (for reviews, see Refs. 9-11). Data
from PCR studies have demonstrated that
the prevalence of Y chromosome microdele-
tions among men with nonobstructive idio-
pathic azoospermia or severe oligozoosper-
mia ranges from 3 to 55.5% (5-8,12-22), the
higher frequencies being detected in cases of
severely impaired spermatogenesis (11). A
number of factors have been implicated in
the wide variation of Y deletion frequencies
reported such as patient selection criteria,
experimental designs, environmental influ-
ences and ethnic variations (22-27). In the
present paper, we report the prevalence of Y
chromosome deletions in a Brazilian popu-
lation of nonobstructive azoospermic and
severely oligozoospermic men attending our
university-based outpatient clinic.
Material and Methods
Patients
DNA samples from 60 patients referred
to the Section of Human Reproduction, Gy-
necology and Urology Division, Universida-
de Federal de São Paulo-Escola Paulista de
Medicina (UNIFESP-EPM) and who gave
written informed consent to be submitted to
genetic testing were screened for Yq chro-
mosome microdeletions. In addition, 12 fer-
tile men and 2 fertile women were tested as
positive and negative controls, respectively.
The Institutional Ethics Committee at
UNIFESP-EPM approved the study design.
Clinical evidence of obstructive azoosper-
mia, or a history of mumps, injury and cryp-
torchidism were not observed in the selected
patients. However, varicocele was not ex-
cluded because in this situation the cause of
infertility is largely unknown and an associ-
ated Y chromosome deletion cannot be ex-
cluded (11). The testis volume was meas-
ured with a Prader orchidometer. Semen
samples were obtained on two different oc-
casions, with each collection being performed
after a 3-day period of sexual abstinence and
separated by a 3-week interval. A complete
semen analysis was performed according to
World Health Organization guidelines (28).
The diagnosis of azoospermia was estab-
lished by pellet analysis after semen cen-
trifugation (1,000 g, 20 min). Of the 60
patients included in this study (mean age: 32
years; range 24-49 years), 29 were diag-
nosed with nonobstructive azoospermia and
31 with severe oligozoospermia (<5 x 106
spermatozoa/ml). First-degree male relatives
of the men diagnosed with Y chromosome
deletions were asked to withdraw blood for
DNA analysis in order to determine if the
deletion was de novo.
Plasma hormone levels
The plasma concentrations of follicle-
stimulating hormone (FSH) and luteinizing
hormone (LH) were measured by immu-
noassay using an IM®X system kit (Abbott Labo-
ratories, Abbott Park, IL, USA), while plasma
testosterone levels were determined by ra-
dioimmunoassay using a Coat-A-Count®
Testosterone Total kit (Diagnostic Products
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Co., Los Angeles, CA, USA) according to
manufacturer instructions. Normal reference
ranges for men are FSH 1-12 mIU/ml, LH 2-
12 mIU/ml and testosterone 262-1593 ng/dl.
DNA isolation and Y chromosome analysis
by PCR
To screen for microdeletions in the Y
chromosome by PCR, genomic DNA was
isolated from lymphocyte nuclei according
to standard protocols. Each individual was
analyzed for the presence of 12 STS on Yq
spread over intervals 5 and 6 in the following
subregions: AZFa (sY82, sY84, sY86), AZFb
(sY117, sY142, sY143), AZFc (sY147,
sY149, sY254, sY255, sY283, sY158). The
STS sY160 in the heterochromatin region
outside AZF regions was also analyzed. The
STS sY14, which is localized in Yp, was
used as a positive control for the presence of
Y-specific DNA. All STS primers, shown in
Table 1, have been previously described
(2,3,5,7). PCR analysis was performed on 25
µl of reaction volume containing genomic
DNA (100 ng), deoxyribonucleotides (0.1
mmol/l each), Taq polymerase (1.25 U), and
oligonucleotide primers (1 µmol/l each) at a
final concentration of 1 x PCR buffer (20
mmol/l Tris-HCl, pH 8.4, 50 mmol/l KCl,
3 mmol/l MgCl2). Primers sY117, sY143,
sY283, and sY160 were amplified in the
presence of 6 mmol/l MgCl2. Amplifications
were obtained with an Idaho Rapidcycler
(Idaho Technologies, Idaho Falls, ID, USA)
under the following conditions: initial 2 min
of denaturation at 94ºC followed by 35 se-
quential cycles, each including 30 s at 94ºC,
40 s at 58ºC, and 20-60 s at 72ºC. The PCR
products were separated on 2.5% agarose
gels by electrophoresis, stained with ethi-
dium bromide, and photographed. During
optimization of the PCR conditions, genom-
ic DNA from fertile men and women served
as normal and Y-deleted controls, respec-
tively. The authenticity of the PCR products
was confirmed by direct nucleotide sequenc-
ing performed with an ABI PRISM™ 377
automated sequencer (Applied Biosystems,
Foster City, CA, USA) and the BigDye™
Terminator Sequencing kit (Applied Biosys-
tems).
Cytogenetic evaluation
Chromosome analysis was carried out on
peripheral lymphocytes with G-banding
staining by the method of Moorhead et al.
Table 1. Sequence-tagged sites (STS) and primer sequences used for Y chromosome
microdeletion analysis.
STS Primer sequence Size (base pairs)
sY14 Forward 5’ GAATATTCCCGCTCTCCGGA 3' 472
Reverse 5’ GCTGGTGCTCCATTCTTGAG 3'
sY82 Forward 5’ ATCCTGCCCTTCTGAATCTC 3' 264
Reverse 5’ CAGTGTCCACTGATGGATGA 3'
sY84 Forward 5’ AGAAGGGTCTGAAAGCAGGT 3' 320
Reverse 5’ GCCTACTACCTGGAGGCTTC 3'
sY86 Forward 5’ GTGACACACAGACTATGCTTC 3' 326
Reverse 5’ ACACACAGAGGGACAACCCT 3'
sY117 Forward 5’ GTTGGTTCCATGCTCCATAC 3' 452
Reverse 5’ CAGGGAGAGAGCCTTTTACC 3'
sY142 Forward 5’ AGCTTCTATTCGAGGGCTTC 3' 196
Reverse 5’ CTCTCTGCAATCCCTGACAT 3'
sY143 Forward 5’ GCAGGATGAGAAGCAGGTAG 3' 311
Reverse 5’ CCGTGTGCTGGAGACTAATC 3'
sY147 Forward 5’ TTTCTCGTTTGATGATCCTAG 3' 100
Reverse 5’ TTAATATGAGAATGAGAACAGATGT 3'
sY149 Forward 5’ TGTCACACTGCCCTAATCCT 3' 132
Reverse 5’ TGGTCATGACAAAAGACGAA 3'
sY254 Forward 5’ GGGTGTTACCAGAAGGCAAA 3' 350
Reverse 5’ GAACCGTATCTACCAAAGCAGC 3'
sY255 Forward 5’ GTTACAGGATTCGGCGTGAT 3' 126
Reverse 5’ CTCGTCATGTGCAGCCAC 3'
sY283 Forward 5’ CAGTGATACACTCGCACTTGTGTA 3' 497
Reverse 5’ GTTATTTGAAAAGCTACACGGG 3'
sY158 Forward 5’ CTCAGAAGTCCTCCTAATAGTTCC 3' 231
Reverse 5’ ACAGTGGTTTGTAGCGGGTA 3'
sY160 Forward 5’ TACGGGTCTCGAATGGAATA 3' 236
Reverse 5’ TCATTGCATTCCTTTCCATT 3'
The size of the expected amplified DNA product is indicated for each STS.
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(29). Karyotypes were obtained in the De-
partment of Genetics, UNIFESP-EPM. On
average, 20-30 metaphases per patient were
analyzed.
Results
Deletion of a specific locus on Yq11 was
indicated by the failure of amplification in
three independent PCR experiments. The
repeated experiments were performed on new
samples of DNA extracted from a different
blood collection. No microdeletions were
observed in any of the fertile men tested.
Overall, 4 of the 60 infertile patients tested
(6.7%) exhibited microdeletions of the Y
chromosome, 2 of them being severely oli-
gozoospermic patients (P10 and P32) and 2
azoospermic men (patients P47 and P57).
The severely oligozoospermic patients P10
and P32 failed to amplify STS sY254, sY255
and sY283, which amplify parts of the DAZ
gene in the AZFc region. Azoospermic pa-
tients presented larger deletions. Deletions
of STS located in the AZFa (sY84, sY86)
and AZFc regions (sY147, sY254, sY283,
sY158) were found in patient P47, while
deletions in the AZFb (sY142) and AZFc
regions (sY254, sY255, sY283, sY158) were
found in patient P57. Patients P47 and P57
did not amplify sY160, an STS localized in
the Y heterochromatin outside the AZF re-
gions. Patients P10 and P32 had microdele-
tions that could not be detected by classical
cytogenetic analysis, both presenting a mor-
phologically normal Y chromosome. Patients
P47 and P57, on the other hand, presented a
46,XY (delY)(q11) karyotype. A schematic
representation of the deletions detected is
given in Figure 1.
Table 1 summarizes the clinical and hor-
monal characteristics of the 4 patients who
presented Yq microdeletions in the PCR-
based studies. Testicular volume was nor-
mal for patients P10 and P47, but reduced
for patients P32 and P57. All 4 patients
carrying Y chromosome deletions presented
elevated plasma FSH concentrations. Plasma
LH and testosterone levels were within the
normal reference range, except for azoo-
spermic patient P57 who presented elevated
LH and reduced testosterone concentration
in plasma.
PCR-based screening and karyotype anal-
ysis of the Y chromosome of the father of
patient P47 and the brothers of patients P32
and P57 were normal. No relative of patient
P10 was available for these tests.
Discussion
In the present study, 4 of the 60 Brazilian
infertile patients diagnosed with nonobstruc-
tive azoospermia or severe oligozoospermia
exhibited deletions of the Y chromosome
(6.7%). Of the 4 infertile men detected with
deletions of the Y chromosome, 2 were non-
obstructive azoospermic men and 2 were
severely oligozoospermic men. Although the
literature indicates a higher frequency of
deletion in azoospermic than in oligozoosper-
Figure 1. Schematic diagram of the human Y chromosome, including AZF regions (AZFa,
AZFb and AZFc) and deletion intervals 5, 6 and 7, as defined by Vogt et al. (6). The list of
sequence-tagged sites (STS) screened by PCR and their localization along the Y chromo-
some is shown. The presence (+) or absence (-) of STS amplification, observed in patients
P10, P32, P47 and P57, is also indicated.
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mic patients (16,22,24), the incidence of
Y chromosome deletions in the present study
was similar in the azoospermic (2/29, 6.8%)
and the severely oligozoospermic patient
groups (2/31, 6.4%). A study on Brazilian
infertile men referred from different infertil-
ity clinics has been recently reported (30).
Among the 65 idiopathic cases of infertility
studied, 6 (9.2%) microdeletions were de-
tected, 3 in the AZFb region and 3 in the
AZFc region. In another study, Carrara (31)
observed Y microdeletions restricted to the
AZFc region in 4.3% (3/70) of Brazilian
infertile men studied. Thus, taken together,
the results indicate that the prevalence of Y
chromosome microdeletions in Brazilian in-
fertile men lies at the lower end of the 3-
55.5% range reported by the literature in
populations of infertile men (5-8,11-22).
Patients P47 and P57, presenting non-
obstructive azoospermia, had several non-
contiguous microdeletions, as already sug-
gested by karyotype analysis [46,XY (delY)
(q11)]. The severely oligozoospermic pa-
tients P10 and P32, on the other hand, pre-
sented microdeletions confined to the AZFc
region, specifically involving the DAZ lo-
cus. Since testicular histology was not avail-
able, a precise genotype/phenotype correla-
tion was not possible in the present study. It
is important to emphasize, however, that all
these 4 patients had in common the presence
of Y chromosome microdeletions confined
to the AZFc regions, specifically in the DAZ
locus, where most Y chromosome deletions
are reported (5,11). Furthermore, the STS-
PCR screening and karyotype analysis of the
father of patient P47 and the brothers of
patients P32 and P57 did not reveal Y chro-
mosome microdeletions, confirming that Yq
deletions were not paternally inherited, but
rather occurred de novo during paternal germ
cell differentiation or during an early stage
of the fertilized egg (7,14,32).
Although all 60 patients analyzed in the
present study were diagnosed as idiopathic
infertile men, the presence of concomitant
varicocele was not excluded during the clini-
cal trial because Y chromosome deletions
can coexist with this pathological condition
(11,16,25,33) and has been defined as idio-
pathic by others (34). Both severely oligozoo-
spermic patients (P10 and P32) carrying Y
chromosome deletions in the present study
had bilateral varicocele. These results are
important for the clinical evaluation of these
patients since it has been suggested that men
with microdeletions and varicocele do not
respond to varicocelectomy (35).
Since Y chromosome inheritance is al-
ways of paternal origin, men with partial
somatic Y chromosome deletions are likely
to have sons with similar genetic defects
after treatment with assisted reproduction
(36-38). Screening for Y deletions would be
indicated in patients undergoing intracyto-
plasmic sperm injection (ICSI) programs and
counseling on the risks of transmitting Y
microdeletions and other Y chromosomal
abnormalities to the offspring should be pro-
vided. Routine screening of Y microdele-
tions in all male patients before ICSI treat-
ment is an important prerequisite for their
appropriate counseling.
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